- Home
- Medical
- Hematology
- Deep Vein Thrombosis
Deep Vein Thrombosis
List Price:
$89.95
- Availability: Confirm prior to ordering
- Branding: minimum 50 pieces (add’l costs below)
- Check Freight Rates (branded products only)
Branding Options (v), Availability & Lead Times
- 1-Color Imprint: $2.00 ea.
- Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
- Belly-Band Wrap: $2.50 ea. (full-color printed)
- Set-Up Charge: $45 per decoration
- Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
- Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
- Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
- RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
Product Details
Author:
Julio McDonell
Format:
Hardcover
Pages:
198
Publisher:
FOSTER ACADEMICS (February 7, 2015)
Language:
English
ISBN-13:
9781632421067
ISBN-10:
1632421062
Dimensions:
5.98" x 9.02"
File:
TWO RIVERS-PERSEUS-Metadata_Only_Perseus_Distribution_Customer_Group_Metadata_20250917125235-20250918.xml
Folder:
TWO RIVERS
List Price:
$89.95
Case Pack:
34
As low as:
$78.26
Publisher Identifier:
P-PER
Discount Code:
F
Pub Discount:
45
Weight:
15.36oz
Imprint:
FOSTER ACADEMICS
Overview
The book presents an elaborative analysis of deep vein thrombosis providing information regarding the risk factors for DVT, vena cava malformation as a novel etiological factor and thrombosis in the upper limbs, post thrombotic syndrome and its management. DVT is usually observed in patients going through major surgeries. This book also extensively elaborates guidelines for thrombo-prophylaxis in orthopaedic patients, laparoscopic operations, radical pelvic surgeries and risks versus benefits in regions where DVT is less prevalent along with an overview of endovascular therapies and imaging in acute DVT, the various challenges in developing countries, and hypercoagulability in liver diseases. Cancer and its treatment are considered as risk factors for VTE and prolonged prophylaxis in ambulatory cancer patients is discussed.
